By comparison, due to the factor of IL-38 dose, the expression of OPG in serum of CLH group was significantly increased, and the RANKL and RANK was significantly decreased (P<0.05 vs CLL&CIA). The gene discussed is TNFRSF11A; the disease is B-cell chronic lymphocytic leukemia.